Manual of Mental Disorders

  • Most Popular
  • Most Shared

REUTERS SHOWCASE

Arthritis Drug

Arthritis Drug

U.S. approves Novartis drug Ilaris to treat childhood arthritis  Full Article 

Dementia & Longevity

Dementia & Longevity

Could family longevity protect against dementia?  Full Article 

Obamacare Expansion

Obamacare Expansion

Kentucky governor announces Medicaid expansion under Obamacare  Full Article 

Gum Stopped

Gum Stopped

Wrigley halts production of caffeine gum following FDA concern  Full Article 

Premature Babies

Premature Babies

Could vaginal delivery be safer for preemies?  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage 

Officials issue warning over fentanyl patches

Related Topics

Stocks

   

Fri Apr 20, 2012 4:24am IST

(Reuters) - U.S. health officials warned on Thursday about the sometimes deadly effect of overexposure to fentanyl painkiller patches, particularly for small children, saying at least 10 people have died and 12 hospitalized in the last 15 years.

In a safety alert, the U.S. Food and Drug Administration said a majority of the 26 cases of accidental exposure to fentanyl observed since 1997 involved children below the age of two.

"(These incidents) reinforce the need to talk to patients and their families to make sure that these patches are stored, used and disposed of carefully," an FDA official said.

Makers of fentanyl patches include Mylan Inc and Watson Pharmaceuticals.

The FDA recommended keeping the patches out of the sight and reach of children and suggested patch-users cover the patch with an adhesive film to make sure it stays on the body.

(Reporting by Zeba Siddiqui in Bangalore; Editing by Tim Dobbyn)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.